NCT06556550View on ClinicalTrials.gov

Stereotactic Radiotherapy for Oligometastasis (1-5) in Various Tumor Sites vs. Palliative Care

PHASE2/PHASE3RecruitingINTERVENTIONAL
Enrollment

100

Participants

Timeline

Start Date

May 31, 2024

Primary Completion Date

December 31, 2028

Study Completion Date

December 31, 2029

Conditions
Oligometastatic Disease
Interventions
RADIATION

stereotactic ablative radiation therapy

stereotactic ablative radiation therapy in effective doses to each metastatic site

RADIATION

palliative radiation therapy

palliative radiation therapy (8 Gy/1 Fx, 3 Gy x 10-15 Fx, 4,5 Gy x 5 Fx)

DRUG

Chemotherapy

prescribed drug line

Trial Locations (1)

249033

RECRUITING

A. Tsyb Medical Radiological Research Center, Obninsk

All Listed Sponsors
lead

National Medical Research Radiological Centre of the Ministry of Health of Russia

OTHER